Iovance Biotherapeutics (IOVA) Revenue (2010 - 2026)
Iovance Biotherapeutics (IOVA) revenue from Jun 30, 2010 to Mar 31, 2026. The TTM Iovance Biotherapeutics (IOVA) revenue is $286M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Revenue
Quarterly Revenue
Iovance Biotherapeutics (IOVA) Revenue CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +34.29% |
Annual Revenue change of Iovance Biotherapeutics (IOVA)
| Year | Revenue | Change |
|---|---|---|
| 2026 | $71M | -72.89% |
| 2025 | $264M | +60.60% |
| 2024 | $164M | +13687.39% |
| 2023 | $1.19M | N/A |
| 2022 | $0 | N/A |
| 2021 | $0 | N/A |
| 2020 | $0 | N/A |
| 2019 | $0 | N/A |
| 2018 | $0 | N/A |
| 2017 | $0 | N/A |
| 2016 | $0 | N/A |
| 2015 | $0 | N/A |
| 2014 | $0 | N/A |
| 2013 | $0 | N/A |
| 2012 | $0 | N/A |
| 2011 | $0 | N/A |
| 2010 | $0 | N/A |
| 2009 | $0 | N/A |
| 2008 | $0 | N/A |